Dr. Ariyan is a board-certified general surgeon specializing in surgical oncology with a clinical expertise in melanoma and soft tissue sarcoma. Her research investigates new ways to allow the immune system to fight cancer. She is also involved in clinical trials aimed at defining the role of current therapies and improving outcomes through novel new treatments. She is currently the principal investigator (PI) of a Phase II trial investigating the addition of systemic ipilimumab to isolated limb infusion for melanoma in transit disease. Dr. Ariyan is also the Memorial Sloan Kettering PI of the multi-center MSLT-II trial. This trial randomizes patients with a positive sentinel lymph node to completon lymph node dissection versus ultrasound surveillance of the lymph nodes.
Education & Training
- University of Vermont College of Medicine, MD
- Yale University, PhD